Open Journal of Blood and Lymphatic Cancer is a peer reviewed scholarly open access journal that covers various aspects like Leukaemia, Lymphoma and its causes, risk factors and its prognosis. Blood cancer represents a large group of different malignancies. This group includes cancers of the bone marrow, blood and lymphatic system which includes lymph nodes, lymphatic vessels, tonsils, thymus, spleen and digestive tract lymphoid tissue. Leukaemia and myeloma, which start in the bone marrow and lymphoma which starts in the lymphatic system are the most common types of blood cancer. Open Journal of Blood and Lymphatic Cancer provides a unique platform that helps to collect and disseminate the scientific understanding in its diagnosis, prevention and treatment.
Aim and Scope
Open Journal of Blood and Lymphatic Cancer aims to develop science and related
research at an international level particularly in the field of blood and
lymphatic cancers. In order to achieve this, it is important to bring it into
limelight to disseminate the outstanding research and its results to the world
instantaneously through the latest advances in the domain of Blood and
Open Journal of Blood and Lymphatic Cancer is a scientific journal which covers high quality manuscripts which are both relevant and applicable to the broad field of cancer.
Indexing & Abstracting
All published articles are assigned to Digital Object Identifier (DOI) – Crossref.
All published articles of this journal are included in the indexing and abstracting coverage of:
*Genamics – JournalSeek
*ResearchBib - Academic Research Index
*Free Medical Journals - Geneva Foundation for Medical Education and Research
*International Innovative Journal Impact Factor (IIJIF)
* Directory of Journals indexing
All published articles are permanently archived and available at Gavin Publishers website in HTML and PDF formats.
· Clinical Trials And Observations
· Hematologic Malignancies
· Circulatory System
· Diagnosis And Its Treatment
· Blood Disorders
· Pediatric Blood Cancer
· Abnormality In Blood Cells
· Myelodysplastic Syndromes
· Bone Marrow Transplantation